Rare Disease Day 2021: FDA Shows Sustained Support of Rare Disease Product Development During the Public Health Emergency

As the FDA focuses on the COVID-19 pandemic, the agency also remains dedicated to its crucial role in development of treatments for rare diseases.

Source: FDA Center for Drug Evaluation and Research - What's New - March 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news